Tonix Pharmaceuticals Holding Corp.(NASDAQ : TNXP)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | 0.04% | 53.99 | 0.9% | $1408.53m | |
| JNJ | Johnson & Johnson | -0.19% | 179.20 | 0.7% | $1293.99m | |
| BMY | Bristol-Myers Squibb Co. | 0.01% | 77.60 | 1.0% | $1212.32m | |
| MRK | Merck & Co., Inc. | -0.02% | 92.30 | 0.7% | $1166.77m | |
| ABBV | AbbVie, Inc. | 0.05% | 150.63 | 1.9% | $1100.81m | |
| LLY | Eli Lilly & Co. | 0.22% | 314.16 | 1.1% | $969.38m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | -0.14% | 142.98 | 0.0% | $491.89m | |
| AZN | AstraZeneca Plc | -0.05% | 66.67 | 1.0% | $491.28m | |
| NVS | Novartis AG | 0.19% | 91.43 | 0.2% | $260.33m | |
| GSK | GlaxoSmithKline Plc | -0.26% | 44.30 | 0.2% | $256.90m | |
| VERU | Veru, Inc. | -0.16% | 12.62 | 0.0% | $253.31m | |
| HZNP | Horizon Therapeutics Plc | 0.00% | 90.59 | 5.4% | $196.03m | |
| SGEN | Seagen Inc. | 0.46% | 139.10 | 5.7% | $186.52m | |
| NVO | Novo Nordisk A/S | -0.58% | 106.00 | 0.1% | $181.83m | |
| VTRS | Viatris, Inc. | 0.58% | 12.08 | 0.0% | $166.23m |
Company Profile
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.